Larry Deckelbaum, CSL Behring’s Global Clinical Development Therapeutic Area Head for Cardiovascular, Metabolism, Hematology and Thrombosis, and his wife, Lois, recently pedaled their way along Cape Cod, Massachusetts to help raise awareness of Alpha-1 Antitrypsin Deficiency (Alpha-1). Alpha-1 is a hereditary condition in which the body does not produce a protein known as alpha-1 antitrypsin. The rare disease is also known as genetic chronic obstructive pulmonary disease (COPD) or inherited emphysema.
The Deckelbaums joined nearly 20 CSL Behring employees and their friends for the 34th Escape to the Cape Bike Trek, a 3-day, 160 mile ride, coordinated by the American Lung Association. The event raised more than $215,000 to support educational programs and to fund research.
“I love to cycle and what better way to do it than to support a worthwhile cause with fellow employees,” Deckelbaum said.
CSL Behring’s participants were members of Team Alpha-1, the Alpha-1 Foundation’s cycling team. Team Alpha-1 received the Silver Spoke award for having the most members.
